Antibody-Drug Conjugates (ADCs): Navigating Four Pillars of Safety, Development, Supply Chain and Manufacturing Excellence

By Dr. Kishore Hotha, Global VP, AR&D, Veranova. Article extracted from Hotha, K. (2023) Antibody-Drug Conjugates (ADCs): Navigating Four Pillars of Safety, Development, Supply Chain and Manufacturing Excellence. Advances in Chemical Engineering and Science, 13, 351-362. doi: 10.4236/aces.2023.134024.

Veranova is your next great decision

Discover new ways to advance your science with Veranova.

Contact us